whether an even greater rotation is coming. Now joining us for the hour Josh Brown, Carrie Firestone, Bill Baruch, Jenny Herrington. We'll check the markets where the big story is, the fact that we are down across the board.And if we throw up what the interest rate complex looks like, that could very well be a culprit today. No doubt about that. As we've got rates Get from the Fed in December.That's that seems to be the story today. No. Yeah.I think it's actually part of a bigger story. And I was talking to ...

Core Viewpoint - The biotech sector is showing strong momentum, with significant potential for continued growth, particularly in the context of upcoming mergers and acquisitions (M&A) in 2026 [3][11]. Group 1: Sector Performance - The biotech sector is performing comparably to major tech stocks, indicating a competitive landscape [1]. - Companies like Gilead and Merck are reaching all-time highs, while Bristol Myers is also recovering [2]. - Historical valuations for biotech and healthcare are at historic lows compared to the past five years, suggesting a value opportunity [3]. Group 2: Valuation Insights - The forward price-to-earnings (PE) ratio for the healthcare sector is currently around 18, below the historical average of over 20 [5]. - There is a significant valuation gap, with some companies trading at single-digit or low double-digit multiples, indicating potential undervaluation [6][10]. - The healthcare sector typically represents 10-15% of a traditional portfolio allocation, but many investors are currently underweight in this area [6]. Group 3: Market Dynamics - The recent rotation in the market has favored healthcare, with notable inflows observed in October, marking one of the largest rotation days in years [9]. - The Trump administration's stance appears to have eased pressures on companies like United Healthcare, contributing to a more favorable investment environment [9]. - The potential for M&A activity in the biotech space is high, with companies positioned for strategic acquisitions [11].

Welcome to the great rotation. https://t.co/HJrEV4wOK4Will (@WClementeIII):Am I hallucinating or are we literally watching a gold to Bitcoin rotation on the tape this morning ...

JUST IN: Gold hits most overbought levels ever on its monthly RSI.Rotation into Bitcoin next? https://t.co/zpfcni5nQQ ...

wHaTs tHe neXt rOtAtIoN https://t.co/bxwkuSksmB ...

Rotation incoming?#BTC cooling, #alts starting to breathe.Keep your eyes open 👀 NFA ...

Rotation, rotation, rotation.Profits from #BTC → #ETH → #Alts → Low caps.It’s the playbook. ...

Market Dynamics - The market experiences "rotation" during dips, involving the movement of invested money from one sector, industry, or asset class to another [1] - This rotation is fundamentally a "buy low, sell high" strategy, but sectors can become overly dominant [1] - Overcrowded sectors can lead to disproportionate and punishing effects, similar to too many people rushing for an exit [2] Risk Assessment - Big cap technology's dominance in indices means even small selling can significantly impact the indices [2] - Crowded trades in dominant sectors pose a risk of disproportionate losses [2]

word of the day here which is rotation. When we have a dip, guess what. We see movement of money invested in stocks from one place and you can think sectors here, industries or entire asset classes to another place.>> In its basic form, it's pretty benign, right. I mean, it's it's buy low, sell high. If it were only that simple all the time, a lot of times what happens is sectors become very much in demand or very dominant.And that's clearly been the case with with big cap technology. And the problem is bec ...

Small caps were already riding the wave of a recent rotation out of Big Tech and into lagging parts of the market. Then came dovish remarks from Federal Reserve Chair on Friday, which likely provided more room to the rebound https://t.co/wYiy6fQUUZ ...